William Hornung

Keine laufenden Positionen mehr

55 Jahre

Health Technology

Consumer Services

Ehemalige bekannte Positionen von William Hornung

Unternehmen	Position	Beginn	Ende
DIFFUSION PHARMA	Finanzdirektor/CFO	25.09.2018	15.05.2023
DIFFUSION PHARMA	Corporate Officer/Principal	01.07.2017	25.09.2018
HEPION PHARMACEUTICALS, INC.	Finanzdirektor/CFO	23.06.2014	16.11.2015
PTC THERAPEUTICS, INC.	Finanzdirektor/CFO	01.04.2012	01.03.2014
Elan Pharmaceuticals, LLC Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA.	Corporate Officer/Principal	01.01.1998	01.01.2002

The William Paterson University of New Jersey

Undergraduate Degree

International

Vereinigte Staaten

Operativ

Director of Finance/CFO	3
Corporate Officer/Principal	2
Undergraduate Degree	1

Sektoral

Health Technology	5
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
PTC THERAPEUTICS, INC.	Health Technology
HEPION PHARMACEUTICALS, INC.	Health Technology

Private Unternehmen	2
Elan Pharmaceuticals, LLC Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA.	Health Technology
Diffusion Pharmaceuticals, Inc. Diffusion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.	Health Technology

Private Unternehmen

Health Technology